Research output per year
Research output per year
Personal profile
Biography
Professor Paul A. McCarron holds a Chair in Pharmaceutics and is currently the Head of School of Pharmacy and Pharmaceutical Sciences at Ulster University.A registered pharmacist and member of the Pharmaceutical Society of Northern Ireland, with experience of industrial and academic pharmacy, he has a particular interest in the development of advanced drug delivery systems with a expertise in translating novel delivery strategies into the clinical and commercial settings.He is currently a company director in Swedish Pharma and founder of Jenarron Therapeutics Ltd. Both companies are at an early stage and in the preliminary rounds of raising seed capital funding to develop innovative topical dosages forms. The former company is concentrating on the development of bioadhesive oral patches, whilst Jenarron Therapeutics is commercialising a wound hydrogel for use in management of chronic wounds and acute laceration.Research InterestsProf McCarron’s research interests concern the development and characterisation of nanoparticulate systems and topical formulations. Following substantial funding from the Research and Development Office in Northern Ireland, Prof McCarron developed and trialed an innovative putty-type material for delivering anaesthesia to acute laceration.Results published recently in the Annals of Emergency Medicine, the foremost journal for emergency medicine research, demonstrate efficacy based on a non-inferiority study when compared to infiltration of lidocaine solution.FundingDepartment of Education for Northern Ireland.
External positions
Registered Pharmacist, Pharmaceutical Society of Northern Ireland
1 Jan 1990 → …
Keywords
- RL Dermatology
- RM Therapeutics. Pharmacology
- RS Pharmacy and materia medica
Fingerprint
Dive into the research topics where Paul Mc Carron is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Targeting LIN28: a new hope in prostate cancer theranostics
Shrivastava, G., Aljabali, A. A., Shahcheraghi, S. H., Lotfi, M., Shastri, M. D., Shukla, S. D., Chellappan, D. K., Jha, N. K., Anand, K., Dureja, H., Pabari, R. M., Mishra, V., Almutary, A. G., Alnuqaydan, A. M., Charbe, N., Prasher, P., Negi, P., Goyal, R., Dua, K., Gupta, G. & 9 others, , 15 Jul 2021, (E-pub ahead of print) In: Future Oncology. 13 p.Research output: Contribution to journal › Article › peer-review
-
The viral capsid as novel nanomaterials for drug delivery
Aljabali, A. A., Hassan, S., Pabari, R. M., Shahcheraghi, S. H., Mishra, V., Charbe, N. B., Chellappan, D. K., Dureja, H., Gupta, G., Almutary, A. G., Alnuqaydan, A. M., Verma, S. K., Panda, P. K., Mishra, Y. K., Serrano-aroca, Á., Dua, K., Uversky, V. N., Redwan, E. M., Bahar, B., Bhatia, A. & 5 others, , 13 Jul 2021, In: Future Science OA. FSO744.Research output: Contribution to journal › Article › peer-review
Open Access -
Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1 alpha
A.a. Aljabali, Bakshi, H., L. Hakkim, A. Haggag, Al-Batanyeh, K. M., S. Al Zoubi, Al-trad, B., Nasef, M., Satija, S., Mehta, M., Pabreja, K., Mishra, V., Khan, M., Abobaker, S., Azzouz, I. M., Dureja, H., Pabari, R. M., Dardouri, A. A. K., Kesharwani, P., Gupta, G. & 11 others, , 1 Jan 2020, In: Cancers. 12, 1, p. 1-22 113.Research output: Contribution to journal › Article › peer-review
Open AccessFile36 Citations (Scopus)35 Downloads (Pure) -
Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens
Pardhi, D. M., Şen Karaman, D., Timonen, J., Wu, W., Zhang, Q., Satija, S., Mehta, M., Charbe, N., Mccarron, P., Tambuwala, M., Bakshi, H. A., Negi, P., Aljabali, A. A., Dua, K., Chaellappan, D. K., Behera, A., Pathak, K., Watharkar, R. B., Rautio, J. & Rosenholm, J. M., 30 Aug 2020, In: International Journal of Pharmaceutics. 586, 21 p., 119531.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Citations (Scopus)84 Downloads (Pure) -
Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells
Haggag, Y., Abu Ras, B., El-Tanani, Y., Tambuwala, M. M., McCarron, P., Isreb, M. & El-Tanani, M., 15 Sep 2020, In: Expert Opinion on Drug Delivery. 17, 11, p. 1655-1669 15 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)20 Downloads (Pure)